BioMarin Pharmaceutical, Inc. (BMRN)

55.58 +0.99 (+1.81%) USD  |  NASDAQ  |  Jan 20, 13:50
More

BioMarin Pharmaceutical Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Biogen, Inc. Upgrade